LEXINGTON, Mass., June 24 /PRNewswire/ -- Instrumentation Laboratory (IL) today announced that it has shipped its 1000th GEM Premier 4000 critical care analyzer. The recipient for this instrument was Scripps Health, based in San Diego, CA. IL began shipping the new GEM Premier 4000 analyzers to customers around the world in September 2006. The remarkable commercial success of this breakthrough analyzer underlines its tremendous customer appeal.
Scripps Health, a $2 billion, non-profit community health system, treats a half-million patients annually through the dedication of 2,600 affiliated physicians and 11,600 employees among its five acute-care hospital campuses, home health care services, and an ambulatory care network of clinics, physician offices and outpatient centers. In addition to receiving the 1000th GEM Premier 4000, Scripps has already placed 18 of the new analyzers in labs and point-of-care locations, including the emergency room, critical care unit, intensive care units, neonatal intensive care units, operating rooms and respiratory therapy departments in its five hospital campuses. Scripps has truly standardized its critical care testing with the GEM Premier 4000.
"The GEM Premier 4000 is such a versatile instrument that we are able to use it throughout our hospital network. It is easy to use and requires so little maintenance, that end-users can operate it anywhere in the hospital, and we can be assured they are performing the tests correctly and receiving accurate results right away," said Chris Nicholson, administrative director for hospital labs at Scripps Health. "We have also been successfully using GEMweb(R) Plus information management system, which gives our end-users ultimate control of all the analyzers in the network, even remotely."
Healthcare providers around the globe have embraced the GEM Premier 4000 for its revolutionary simplicity and flexibility at the point of care and in the lab. With its automated quality control system, Intelligent Quality Management (iQM(R)) and the addition of integrated CO-Oximetry, the GEM Premier 4000 delivers the breadth of tests and the quality of results customers need to deliver the best in patient care.
"Customer satisfaction with the GEM Premier 4000 has been exceptionally high. Laboratorians and point-of-care providers, alike, truly appreciate that the analyzer requires virtually no maintenance and gives them great confidence in their test results," said Brian Durkin, Director of Sales and National Accounts at IL. "We are very proud to ship our 1000th unit to Scripps Health, a renowned hospital network with a solid reputation for remaining at the forefront of medical developments and delivering the highest quality healthcare."
Additionally, accompanying this milestone event is the significant customer acceptance and success of GEMweb Plus, IL's advanced information management system, already used by nearly half of the GEM Premier 4000 customers in the US. GEMweb Plus software gives customers ultimate control of all networked GEM Premier 4000 analyzers from any location.
Instrumentation Laboratory (www.ilus.com), founded in 1959, is a worldwide developer, manufacturer and distributor of in vitro diagnostic instruments, related reagents and controls for use primarily in hospitals and independent clinical laboratories. The company's product lines include critical care systems, hemostasis systems and information management systems. IL's GEM product offerings, part of the critical care line, include the new GEM(R) Premier(TM) 4000 analyzer with Intelligent Quality Management (iQM(R)), GEM Premier 3000 analyzer, GEM OPL(TM), a portable whole blood CO-Oximeter and the GEM PCL Plus, a portable coagulation analyzer. IL's hemostasis portfolio includes the ACL TOP(R), a fully automated, high-productivity analyzer and the ACL ELITE and ELITE PRO, the latest additions to the ACL family. IL also offers the HemosIL(R) line of reagents. IL is based in Lexington, Massachusetts.
CONTACT: Sally McCraven of Instrumentation Laboratory, +1-781-861-4577
Web site: http://www.ilus.com//
